CIPLA Share Price, Forecast, News and Quotes - Equitymaster
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA Share Price   (CIPL)

Here is the latest stock price and chart of Cipla. For more details, see the Cipla company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Jan 18, 2017 09:16:00 AM
Price (Rs)589.50 Open (Rs) 588.00 High (Rs) 595.00 Low (Rs) 588.00
% Change0.51 Volume 428 Value (Rs) 252,306 52-Week H/L 617.70 / 458.25
Live NSE Quotes Jan 18, 2017 9:19:59 AM
Price (Rs)589.70 Open (Rs) 588.80 High (Rs) 591.00 Low (Rs) 587.80
% Change0.42 Volume 15,720 Value (Rs) 9,266,626 52-Week H/L 617.80 / 457.45
Valuation
EPS (Rs)* 14.22 P/E Ratio (x) 41.45 Market Cap (Rs m) 474,081.80 P/BV (x) 4.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
CIPLA Stock Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new


Today's Market

GST Rollout is a Major Step Forward in these Vindictive times(Pre-Open)

The goods and services tax (GST) is set to be rolled out from 1st July after the centre and the states reached an agreement on the contentious issue of the sharing of administrative powers.

Related Views On News

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Cipla: Impacted by one offs (Quarterly Results Update - Detailed)

Jun 2, 2016

Cipla has announced its 4QFY16 results. The company has reported 7.6% YoY growth in sales and a decline of 68.9% YoY in net profits. Here is our analysis of the results.

Cipla: Quarter Impacted by One-Offs (Quarterly Results Update - Detailed)

Apr 6, 2016

Cipla has announced its 3QFY16 results. The company has reported 15.3% YoY and 4.7% YoY growth in sales and net profits respectively.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

More Views on News

Most Popular

Demonetisation was NOT about Black Money. Here's Proof...(The 5 Minute Wrapup)

Jan 5, 2017

A not-so-shocking report confirms our suspicion.

Try to Imagine Your Own Funeral...(Vivek Kaul's Diary)

Jan 7, 2017

In the end...does it matter where Toyota builds its next plant...when the stock market next crashes...whether you own a mansion?

From Notebandi to Goldbandi(Daily Profit Hunter)

Jan 6, 2017

Asad Dossani discusses Demonitisation 2.0: Goldbandi. A hypothetical, but possible, event that could shape the gold market in 2017.

An IRR comparison for Hidden Treasure, Small cap index and Sensex(Chart Of The Day)

Jan 7, 2017

2016, with all its surprises, has laid a strong foundation for small cap businesses.

Will You Accumulate Money or Accumulate Value?(Outside View)

Jan 11, 2017

In life one must continue to add value wherever possible and inculcating this attitude will create long term wealth.

More

TRACK CIPLA

CIPLA - FRESENIUS KABI ONCO. COMPARISON

Compare Company With Charts

COMPARE CIPLA WITH

MARKET STATS